ABSTRACT: Aerosol-assisted atmospheric pressure plasma allows for a one-step synthesis of vancomycin-containing nano-capsules. Morphological and chemical analyses were carried out to estimate how different discharge parameters affect the plasma deposition process. Nano-capsules size and abundance largely depend on the shell precursor content in the gas feed and on the drug concentration in the aerosol solution. Based on these results a deposition mechanism is proposed, where, interestingly, the key step is the formation of the nano-capsules in the plasma phase.
Introduction
Nano-capsules are nanometric vescicular systems with a core-shell structure consisting of a cavity and a surrounding polymeric membrane or coating. An active compound can be contained inside the cavity, in liquid or solid form, or even as a molecular dispersion; the active substance can also be carried at the surface of the nano-capsules or imbibed in their polymeric membrane.
The most widely investigated application of nano-capsules is probably as drug delivery systems. [1] [2] [3] Numerous qualities make these systems extremely suitable and vastly used for drug delivery: the subcellular size of nano-capsules, for example, allows more efficient uptake of the compounds in cells. Other interesting qualities are: improved stability of the active substance in the capsule, biocompatibility and biodegradability, high drug-encapsulation efficiency, and shell protection of the drug against degradation factors. These systems generally aim at delivering a specific drug where required, rather than in the entire body, in low amount rather than in massive quantities, avoiding a high risk of developing resistance. The ideal amount of antibacterial compounds released should be higher than the Minimum Inhibiting Concentration (MIC) of the target organisms, but well below the cytotoxicity threshold. The technological issue concerning nano-capsules synthesis is raising great interest. Classical methods for the preparation of nano-capsules are: nano-precipitation, emulsiondiffusion, double emulsification, emulsion-coacervation, polymer-coating and layer-by-layer technique. 4 Nano-capsules containing a bioactive molecule can be considered a biocomposite material with a very peculiar morphology. Biocomposite coatings, in general, consist of two fundamental components: a bioactive molecule, and a matrix in which the molecule is embedded. The nature of the molecule and that of the matrix can be properly selected in order to obtain different coatings for a very wide range of applications, including food packaging, 5, 6 biosensors, [7] [8] [9] [10] [11] [12] [13] [14] [15] and bioreactors. [16] [17] [18] In the biomaterials field, particularly for tissue engineering and regenerative medicine applications, biocomposite coatings are being tested as drug delivery systems, with the aim of providing antibacterial or enhanced cell-growth properties either on 3D scaffolds 19, 20 or on flat substrates. [21] [22] [23] [24] [25] [26] A huge variety of processes have been studied to achieve the synthesis of biocomposite coatings; the most relevant are: photo-polymerization, 27 initiated-Chemical Vapor Deposition (i-CVD), 22 3D
printing, 19 micro-dispensing 21 and wet chemistry. 13, 20, 28, 29 All the above-mentioned techniques for nano-capsules and biocomposite coatings synthesis present in general some drawbacks, especially for the scale-up of the process; for example, multi-step protocols are often proposed, that include the use of potentially harmful solvents and reagents. Plasma processes may provide a solution to reduce these drawbacks; moreover, they allow fine tuning of coating properties without altering the bulk properties of the target material, with limited use of chemicals and solvents. 30, 31 A one-step process has been optimized by Palumbo et al. 32 for the plasma deposition of nanometric hydrophilic biocomposite coatings embedding active Lysozyme, an antimicrobial enzyme. The deposition method is developed in an Atmospheric Pressure Plasma (APP) reactor configured as Dielectric Barrier Discharge (DBD), coupled with an atomizer to feed the gas discharge low vapor pressure pure liquids, salts solutions and suspensions of nano-particles. [32] [33] [34] [35] [36] [37] [38] [39] [40] 47 This configuration allows the deposition on any kind of flat substrate.
To deposit the biocomposite coatings the aerosol solution atomized into the reactor must contain the bioactive molecule dissolved in a suitable solvent. The matrix precursor is also inlet into the reactor, as gas or vapor, along with a buffer gas (e.g., He, Ar) to generate the aerosol and to sustain the discharge. When the feed passes through the discharge, the precursor and the vapour of the solvent are fragmented in radicals and atoms that originate the matrix of the coating; at the same time, nanometric drops of the aerosol are present in the plasma environment and participate to the deposition process. The bioactive molecule in the droplets is protected against the plasma environment, and is found unaltered embedded in the final coating, with retained structure and activity. [33] [34] [35] Thanks to the mild discharge conditions, aerosol-assisted APP processes enable the use of thermo-degradable molecules providing easy-to-handle technical equipment.
Vancomycin is a glycopeptide antibiotic produced by Streptococcus Orientalis, well known for drug delivery applications, with a broad-spectrum activity, including against methicillin-resistant strains of Staphylococcus aureus. Vancomycin has often been encapsulated in spherical micro/nanoparticles made of polymeric materials such as poly(ε-caprolactone), for bone implants, 41 spray dried chitosan, 42 or N-trimethyl chitosan, prepared by single ionic complexation. 43 Vancomycin-containing coatings produced by electrodeposition [44] [45] [46] and adsorption methods 46 are also reported.
We have recently published a communication on the direct synthesis of vancomycin-containing nanocapsules using an aerosol-assisted APP process. 47 It represents an absolute novelty since, for the first time, a one-step, easy-to-handle, eco-friendly, plasma process is shown for the synthesis of nanocapsules embedding a bioactive molecule. As for previous works 32, 47 ethylene was selected as precursor of the shell of the capsules; vancomycin was selected to be embedded in the capsules from an aqueous aerosol, helium was used as buffer and aerosol-forming. Surprisingly, in specific experimental conditions, layers of nano-capsules resulted on the zone close to the gas inlet of the ground electrode of the DBD, instead of a flat coating embedding the biomolecule. 32 The experiments in this paper highlight more in detail how the variation of some discharge parameters can affect the morphology and the deposition mechanism of vancomycin-embedding nano-capsules.
Furthermore, the optimized materials have been tested for their drug-release properties in water, as well as for their antibacterial activity. The analysis of the antibacterial activity has been carried out on films deposited onto titanium disks (grade 2, 10 mm dia, VDM metals, Germany) polished with colloidal silica suspension (0.05 μm size, Buehler, USA).
Experimental Section

Materials
DBD Reactor
The homemade DBD reactor is the same as the one schematically shown in ref [32, 47] . It consists of two parallel plates silver electrodes, 5×8 cm 2 wide, 5 mm apart, both covered with 0.63 mm thick alumina sheets. The electrode set up is confined in a sealed Plexiglas chamber. The aerosol of 0-15 mg/mL vancomycin aqueous solution was generated with an atomizer (mod. 3067, TSI) working with
He at a flow rate of 5 slm. Previous works indicated that in this condition a mass flow rate of 136±7 µg/min of aerosol was obtained. As stated by different authors 33, 34 the diameter range of the droplets produced by the atomizer, used in the present work, in similar conditions is typically sub-micrometric.
Ethylene was fed in the chamber at a flow rate of 5-200 sccm, and an auxiliary line allowed He to be directly inlet in the chamber when needed. Gas flow rates were controlled by means of electronic mass flow controllers (MSK instruments). The gas/aerosol feed was let from the shorter side of the reactor, through the plasma zone between the electrodes, and was pumped out by an aspirator located on the opposite side. The Continuous Wave (CW) discharge was ignited between the electrodes using a corona power supply (PVM500, Information Unlimited). The electrical properties of the plasma were investigated for determining the voltage and the current delivered to the system with a high- goniometer (5ml drop, double distilled water).
Vancomycin release tests
Plasma processed samples 1x2 cm 2 wide were put into 12-well Iwaki polystyrene plates with flat base (Sterilin Limited, Newport, UK), covered with 800 μL of water, and incubated at room temperature. Ti samples were placed upside down in the plate. The plates were then incubated overnight at 37 ºC and the zone where the growth of bacteria is inhibited was measured around the samples.
The growth inhibition (double-well) test, instead, was performed in order to evaluate the dynamic antibacterial activity of eluents from the samples. A 48 wells plate (Nunc) with adjacent pair wells connected was used: one for the titanium sample and the other one for the measurement of the bacteria growth curve by UV-vis spectrophotometer, as previously reported. 49 Bacteria for this assay were grown overnight and diluted to an optical density of 0.02, corresponding to 10 6 CFU/mL. A 1mL aliquot of suspension was placed in each well and the absorbance at 600 nm was monitored with a multiplate reader (Multimode microplate reader, Synergy™ HTX) every 10 min. Before each measurement, the plate was shaken for 3 s to ensure the homogeneity of the suspension.
Results and discussion
Characterization of the coatings
In our previous work 47, we presented the core-shell organization of the vancomycin-containing nano-capsules constituting the APP deposited coatings obtained from continuous and modulated plasma. The structure of the capsules could be easily detected and it was also observed that, when deposited in continuous mode, the spherical structures appeared bigger than those formed in DBDs ignited in pulsed mode, where taller aggregates of slightly smaller spheres were formed (Figure 1a and 1b). After immersion of the samples in water, the PM coating largely delaminated 47 , whereas the CW one showed just a 17% decrease in thickness, and moreover in the latter some of the spheres opened revealing a cavity, or collapsed upon themselves, as clearly shown in Figure 1c The results shown so far led us to hypothesize the deposition mechanism schematically illustrated in Figure 5 for the nano-capsules formation; the advancement of the deposition process is a function, amongst other parameters, of the distance from the feed inlet and the deposition time. In particular, it is possible to identify three main steps:
I. ethylene molecules enter in the plasma zone with He carrier (not shown in the scheme), along with the aerosol droplets containing water and vancomycin;
II. partial evaporation from the aerosol droplets and fragmentation of water takes place in the plasma zone, along with the fragmentation/activation of the ethylene precursor, giving rise to polymerization both at the surface of the substrate and at the surface of the aerosol droplets;
at the same time the droplets, coated and uncoated, adsorb at the surface of the substrate where the polymerization proceeds;
III.
The droplets adsorbed at the surface of the substrate become partially covered by and embedded in the growing hydrocarbon-like matrix. At the end of the deposition process, the overall deposited layer results composed by spherical nano-capsules partially embedded in or leant on a flat film; the spheres are composed by a vancomycin-containing core and a hydrocarbon polymer-like shell. The SEM morphological analyses illustrated in this paper well support the hypothesis formulated on the aerosol-assisted APP deposition mechanisms of the nano-capsule layer. It has to be stressed that the deposition of the nano-capsules occurs, also when other kind of solute is used in the aerosol, in the plasma zone close to the feed inlet, where the feed meets the discharge. More pieces of discussion on the deposition mechanism are delivered below.
If we consider the effect of the ethylene flow rate shown in Figure 2 , for example, the low density of spheres obtained at 5 sccm of C2H4 could be explained by the low amount of polymer precursor fragments available to coat all nanodroplets in the discharge; most of the water evaporates from the nanodroplets, and this results in less spheres at the surface of the substrate. When 200 sccm of C2H4 are fed, instead, the density of precursor fragments is high enough to initiate a fast polymerization at the surface of the droplets, even the small ones, before they evaporate or aggregate; this results in a higher number of spheres in the deposited layer, with a lower diameter compared to coatings deposited feeding the plasma with 20 and 50 sccm C2H4.
Regarding the effect of the deposition time shown in Figure 3 we hypothesize that, as the duration time of the discharge proceeds, more spheres are produced in the plasma zone and lean on the substrate, with the small ones that adhered on the bare substrate at the beginning of the deposition process resulting covered and embedded by the growing matrix.
The question could arise about the fate of water, as to whether there is liquid water in the capsules. It is hard to give an exhaustive answer, for the lack of suitable chemical imaging spatially resolved techniques, at the best of the authors' knowledge. However, it is possible to state that though water can be present in the capsules, it should not be in liquid state. In fact, in such a case, once in the ultrahigh vacuum of SEM, capsules should burst during the analysis or at least broken capsules residues should be observed. But such phenomena have never been noticed.
The presence of a solute in the aerosol solution appears to be also relevant to the formation of the nano-capsules, as shown in Figure 4 . Their number and dimension remain constant first, and then decreases with the concentration of vancomycin in the solution, finally absent when a pure water aerosol is used. This effect could probably be explained with the different stability in the plasma zone of nanodroplets containing different amount of vancomycin chloride.
It should be considered that, as reported in our previous paper, 47 nano-capsules were also observed when the aerosol solution contained fluorescein, and Chun-Ping Hsiao et al. 50 reported the presence of similar features when the atomizer was fed with a lysozyme solution. The work carried out up to now, therefore, demonstrates that the presence of a solid solute in the aerosol solution is a key factor in the formation of the spheres. Since the vancomycin concentration used in our experiments is not enough to substantially affect water vapor tension, some effects due to the segregation of the solute at the surface of the nanodroplets could be taken into account. We hypothesize that vancomycin segregates at the surface of the nanodroplets and increases locally the density of the solution; in this way, the droplets surface can better sustain the coating formation. At low or zero concentration, this effect is negligible, thus the coating shell cannot easily form and the water droplet can evaporate or spread over the sample. We can suppose that such molecules can segregate at the drop/gas interface for 2 main reasons: This could be expected since in a pulsed process, part of the time the plasma is off and as a matter of fact, the deposition of the matrix is drastically reduced. Off time likely does not affect vancomycin deposition, which is mostly transferred to the sample by condensation, hence, the drug deposition rate can be considered independent from the pulse or continuous condition. As a result, the coating is enriched in vancomycin passing from continuous to pulse mode. as reported in table 1, N and Cl content in vancomycin is low and, considering that in the coatings the drug is diluted in the matrix, the heteroatoms atomic concentration will be much lower and below the detection limit for XPS.
ii) the escape depth for XPS is much lower than 10nm, and if vancomycin is mostly in the core of the capsules, it cannot be revealed.
The latter point is important and useful for the discussion on nano-capsules structure since it can further prove the core-shell structure of the features found.
On the other hand, in PM some chlorine and nitrogen can be revealed. This can be ascribed to the likely higher concentration of vancomycin in the coating, and much more to the possibility that in PM some vancomycin just adsorb on the coating during the off time, without being embedded in the capsules. Thus, in this kind of samples, vancomycin is more accessible to XPS. Since the main application of the coating is as a drug delivery system, the kinetics of the vancomycin release from the coating was monitored. Water has been used as medium for the release test since the coating is supposed to be, in its end use, in contact with aqueous environment. The release assay was conducted on 1µm thick composite coatings deposited in CW and in PM conditions, both with and without the addition of a top coating. In Figure 7 it can be appreciated that coatings deposited in pulse mode release vancomycin faster, and the addition of a protective layer has no effect on the kinetics. On the other hand, the drug release from the CW film is slower and, in particular, the percentage of released vancomycin is 75% after 100 min, less than 50% with a top coating, while in the same time for the PM case the release is around 90%. Much more, it can be observed that the continuous mode coating takes more than 2 days to release all the leachable drug when the top layer is present. These results can depend on the morphology of the PM film, richer in asperities, offering a higher surface area to contact with water, which makes the release easier and reduces the ability of the top coating to conformably cover the sample surface. 
Antibacterial activity assay
The antibacterial activity was evaluated by the agar diffusion and growth test for coatings deposited onto Ti discs with a thickness of 1µm and a 100 nm barrier coating on top. In the agar diffusion test, it can be observed that the inhibition halo is not evident when the coating is just the matrix, without the drug ( Figure 8a) ; on the other hand, samples coated with vancomycin-containing films give origin to an inhibition zone whose diameter is respectively 3.2 ± 0.1 cm for the CW coating (Figure 8b ) and 3.8 ± 0.5 cm for the PM coating (Figure 8c ). 
Conclusions
The plasma deposition of vancomycin-containing capsules has been investigated and optimized in this work. The morphological SEM analysis seems to indicate that this deposition process mainly depends onto the flow rate of the matrix precursor, C2H4, and the concentration of drug in the aerosol solution. In particular, a solid solute in this solution is necessary, otherwise no capsules appear. It is likely that plasma polymerization of the matrix starts around the aerosol droplets, trapping the vancomycin inside the capsule. FTIR and liquid chromatography confirm the presence of vancomycin in the composite coatings.
The kinetics release study has proven that the addition of a barrier top layer can slow down the drug release rate, only in the case of coatings deposited in continuous mode, likely because of the most complex morphology of PM films. A release, lasting two days, has been obtained with a 100 nm thick top coating.
Bacteria agar diffusion and growth test confirmed the antibacterial activity of the deposited materials, opening up a route to the preparation of drug delivering systems loaded with vancomycin. Despite the complexity of the mechanism hypothesized, this work allowed for a better comprehension of this unique deposition process forming nano-capsules containing drug, by means of atmospheric pressure plasma.
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Drug can be encapsulated in plasma polymerized nano-vescicles by means of aerosol-assisted atmospheric pressure plasma in a dielectric barrier discharge configuration. This is hereby proved for vancomycin containing composite coatings, evidencing the morphology of nanocapsule with a coreshell structure. The growth mechanism proposed is based on the hypothesis that the capsules shell is plasma polymerized around the aerosol nano-droplets before sticking on the substrate. Once deposited such nano-capsules formed film is able to release the drug in water, and much more the antibacterial activity is maintained, as demonstrated against Staphylococcus aureus.
